troke is the second-leading cause of death worldwide and a leading cause of disability.
S
troke is the second-leading cause of death worldwide and a leading cause of disability. 1 Identifying subclinical stroke risk factors may allow for early and potentially more effective stroke prevention measures. One such potential stroke risk factor, silent brain infarction (SBI), is an increasingly detected abnormality with modern magnetic resonance imaging (MRI) techniques. Initially described by Fisher, 2 mounting epidemiological evidence has shown that SBI can contribute to cognitive dysfunction, 3 dementia, 4 and increased overall mortality. 5 However, the most direct potential sequela of SBI is symptomatic stroke. Despite similar pathophysiologic pathways, it is unknown whether SBI and stroke have identical mechanisms given the heterogeneity of SBI in terms of location, mechanism, and underlying risk factors. Furthermore, directly studying the mechanisms of SBI is challenging given that these lesions are incidentally detected and almost always of unknown age. The small size of many SBI, their noneloquent location, and chronic ischemic preconditioning are attractive theories to explain why certain cerebrovascular events do not manifest clinically. 6 Understanding the extent to which MRI-defined SBI predicts the occurrence of stroke is important because if these lesions strongly predict stroke, then their detection might warrant the initiation of a thorough stroke evaluation and more aggressive medical management of stroke risk factors. Also, a more precise quantification of the relative risk (RR) of stroke in the presence of an SBI may allow the adoption of SBI as a surrogate end point in clinical trials and thereby potentially reduce the length
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and expense of trials that would otherwise have relied on stroke as a primary outcome measure. 7 Although there have been many individual studies describing the predictive value of SBI, relying on single-study samples results in wide confidence intervals (CIs) for risk estimates. For these reasons, we performed a systematic review and meta-analysis evaluating whether MRI detection of SBI is a predictor of subsequent stroke.
Methods
We performed this study following the guidelines recommended by the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group 8 and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. 9 We also prospectively registered our study protocol on the International Prospective Register of Systematic Reviews (PROSPERO registration number CRD42014007016).
Data Sources and Searches
A research librarian performed comprehensive searches from database inception on April 3, 2015, in Ovid MEDLINE, Ovid Embase, and the Cochrane Library. An English language filter was not applied. The first search was conducted in Ovid MEDLINE. Subject headings and keywords were adapted for the other databases. Additional records were identified by using the cited by and view references features in Scopus on April 17, 2015 (search methodology details are given in Methods section in the online-only Data Supplement).
Study Selection
We included only studies with MRI characterization of SBI in subjects subsequently followed up for the development of future clinically overt stroke. Specific inclusion criteria were (1) studies of adult subjects (aged >18 years); (2) at least 100 subjects; (3) MRI determination of SBI as lesions measuring ≥3 mm with differentiation of SBI from leukoaraiosis; (4) mean follow-up of >12 months after brain MRI; and (5) clinical ascertainment of stroke during follow-up. In cases where the methods for detecting SBI or outcome data were not clear in the article, we attempted to contact the corresponding author for additional details. Furthermore, if test data from a cohort were published more than once, only the article with the largest personyears of follow-up was included to minimize the analysis of duplicate or overlapping samples.
Data Extraction and Quality Assessment
A single investigator read the title and abstract of all references produced by our database search. After preliminary articles were shortlisted as potentially eligible, the articles were read in their entirety by 2 readers to determine eligibility, with disagreements resolved by consensus. Data were extracted from articles meeting the inclusion criteria by a team of 2 readers using a prespecified data collection template, with disagreements in data extraction resolved by a third tie-breaking reader. Study characteristics that were extracted included the first author of the study, study design (prospective or not), major study inclusion criteria, country of the study, total number of subjects, mean follow-up, SBI status at baseline, and the prevalence of stroke risk factors in the studied populations, including age, sex, hypertension, diabetes mellitus, chronic kidney disease, atrial fibrillation, coronary artery disease, hyperlipidemia, and smoking history. Additional study extraction focused on SBI status and stroke outcomes during follow-up, including the number of subjects with and without SBI at baseline, the number of strokes (all strokes, ischemic strokes, and hemorrhagic strokes) that occurred during follow-up in both SBI-positive and SBI-negative groups, the covariate-adjusted RR measure (hazard ratio [HR] or odds ratio) relating SBI and future stroke, and the specific vascular risk factors for which the RR measures were adjusted in multivariate analyses. Data were also extracted about the imaging definitions of SBI in each study, including MRI magnet field strength, MRI slice section thickness, MRI section gap, SBI size classification, SBI MRI signal characteristics, and means of differentiating SBI from perivascular spaces.
Because no standardized tool exists to assess the risk of bias in observational studies, we adapted the bias assessment criteria adapted from recently published meta-analyses focused on SBI in patients with atrial fibrillation 10 and imaging biomarkers of stroke risk. 11, 12 A total of 11 questions were generated to evaluate potential selection, detection, misclassification, reporting, attrition, and confounding bias 13 (Table I in the online-only Data Supplement). Risks of bias questions were assessed by 2 readers, with disagreements in assessment resolved by a third tie-breaking evaluator.
Data Synthesis and Analysis
We estimated the prevalence of SBI in the included studies and the total person-years of follow-up in each study. Meta-analyses of the individual study crude RRs (ie, RR of stroke in the presence of an SBI) and covariate-adjusted HRs were conducted with the use of StatsDirect statistical software (version 2.7.9; 7/9/2012 StatsDirect Ltd, Cheshire, England). Each pooled risk ratio was calculated using a random effects (DerSimonian-Laird) model, 14 and forest plots were generated to display the individual study risk ratios and the pooled risk ratio. We performed all analyses using a random effects model based on the conservative assumption that included studies did not have exactly the same effect size given the potential for heterogeneity between studies in terms of sample size, subject characteristics, and testing methods. To assess the combinability of the risk ratios, we calculated the P value from the Cochrane Q statistical heterogeneity test. The results of each study were expressed as a risk ratio with a 95% CI. For each meta-analysis, the presence of publication bias was evaluated through a Begg-Mazumdar rank correlation test. All P values <0.05 were considered statistically significant.
We performed subgroup analyses limited to the following patient samples: (1) stroke-free participants recruited from population-based or community-dwelling samples; (2) stroke-free participants in studies with inclusion criteria including at least 1 known stroke risk factor (such as hypertension, diabetes mellitus, atrial fibrillation, coronary artery disease, hyperlipidemia, or chronic kidney disease); and (3) patients with a history of documented previous stroke followed up for recurrent stroke.
Role of Funding Source
This study received no external funding.
Results

Study Selection
We screened a total of 1654 titles and abstracts from which we identified 13 articles that met all inclusion criteria for the systematic review. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] One study 27 that met our inclusion criteria was published after our search was completed during the data extraction phase but was included as it provided follow-up cohort data for an article initially included in our original literature search. 28 Study selection steps are summarized in Figure I in the online-only Data Supplement. A crude RR expressing the association between SBI and incident stroke was calculable in all 13 studies from raw data. The most commonly provided adjusted risk metric was the HR, with 8 studies 15, 17, 19, 20, 22, 23, 25, 27 providing covariate-adjusted HRs of SBI as a predictor of incident stroke. One study provided a covariate-adjusted RR of SBI as a predictor of stroke, 16 and 2 studies 18,24 provided covariate-adjusted or age-and sex-matched odds ratios.
Qualitative Study Characteristics
Of the 13 articles meeting inclusion criteria ( plots of the association between magnetic resonance imaging-determined silent brain infarction and future stroke in all included studies. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Meta-analysis performed using a random effects model, with crude relative risks pooled in (A) and adjusted-hazard ratios pooled in (B). Squares represent point estimates for the effect sizes. The size of the squares is proportional to the inverse of the variance of the estimate. Diamond represents the pooled estimate, and the horizontal lines represent the 95% confidence interval.
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Definitions of SBI and Stroke Outcomes
All studies defined SBI as lesions ≥3 mm that were hyperintense on T2-weighted images (details are given in Table III in the online-only Data Supplement). One study provided additional separate analysis of putative vascular lesions <3 mm that were too small to definitely characterize as SBI. 27 All studies described the use of additional MRI pulse sequences to differentiate SBI from adjacent white-matter leukoaraiosis, with most studies relying on T1-weighted hypointensity as a feature suggestive of SBI rather than nonspecific whitematter leukoaraiosis. There were variable methods used to distinguish SBI from dilated perivascular spaces, including the presence of hyperintensity on T2-weighted fluid-attenuated inversion recovery images, 18,20-22,24,26 proton density hyperintensity, 15, 18, 27 and lesion morphology/location.
19,25
MRI magnet field strengths varied from 0.2 to 3.0 T, with most studies using a 1.5-T scanner. Most studies used clinically based definitions of ischemic stroke based on a focal neurological deficit lasting >24 hours and without evidence of hemorrhage on brain imaging (details are given in Table  IV in the online-only Data Supplement). A majority of studies used a combination of hospital and outpatient medical records and telephone interviews to ascertain stroke outcome events.
Association Between SBI and Future Stroke: Crude RRs
We were able to obtain sufficient raw data to calculate a crude RR for future stroke in the presence of SBI for each of the included 13 studies ( 
Subgroup Meta-Analysis Results
Statistically significant random effects crude RR (Table 1) and adjusted HR (Table 2) were preserved in the following subgroup analyses: (1) stroke-free patients recruited from population-based or community-dwelling studies; (2) strokefree participants in studies with inclusion criteria requiring at least 1 known stroke risk factor, including hypertension, 16 chronic renal disease requiring hemodialysis, 17 diabetes mellitus, 21 or >1 cardiovascular risk factor 26 ; and (3) patients presenting with first-time symptomatic acute stroke followed up for recurrent stroke in whom clinically SBI was evident on baseline imaging performed for the initial acute stroke diagnostic evaluation. Of the studies providing an adjusted HR, the risk of stroke in the presence of SBI conferred ≈2-fold increased risk of future stroke in both stroke-free patients (HR, 2.06; 95% CI, 1.64-2.59) and in patients with previous stroke (HR, 2.00; 95% CI, 1.08-3.71). On the basis of the 5 studies 15, 19, 23, 25, 27 with adjusted HRs derived from populationbased studies of 9483 stroke-free individuals with mean or median study ages between 62 and 76, the prevalence of SBI was 18.7%.
Assessment of the Quality of the Included Studies
The results from the quality assessment questionnaire are shown in Table VI in the online-only Data Supplement. All included studies involved >1 investigator independently evaluating MRI studies for the presence of SBI. In all but 2 studies, 16 ,17 perivascular spaces were systematically differentiated from SBI. In 7 of the 13 studies, 15, 18, 19, [23] [24] [25] [26] the risk of selection bias was minimized by either random selection of subjects or recruitment from a community-dwelling population. Six studies explicitly reported that investigators were blinded to SBI status when determining stroke outcomes. 15, 19, 20, 23, 25, 27 All but 2 studies 21,26 corrected for covariate risk factors in their analysis of the association between SBI and incident stroke and provided an adjusted disease association measure, such as a HR or odds ratio. Five studies 15, 19, 23, 25, 27 had the lowest overall risk of bias, with each of these studies demonstrating low potential for bias in all questions but one. All 5 of these studies were of stroke-free individuals recruited from large populationbased studies, including the Cardiovascular Health Study (CHS), 15 
Discussion
SBI is often incidentally detected in patients during MRI evaluation. In this systematic review and meta-analysis of studies involving >14 000 subjects and >100 000 person-years of follow-up, we found that the presence of SBI conferred an ≈3-fold increased risk of subsequent stroke. After adjustment for potentially confounding vascular risk factors, the presence of an SBI was associated with ≈2-fold higher risk of future stroke. This approximate doubling of the independent risk of incident stroke was seen in both stroke-free patients and patients with previous stroke. Approximately 1 in 5 strokefree individuals in these studies had SBI.
Our results are particularly applicable to stroke-free, community-dwelling individuals aged >60 years who are incidentally found to have an SBI on brain MRI. In our subgroup analysis of 5 large, diverse population-based studies (CHS, ARIC, NOMAS, Rotterdam Scan Study, and the Framingham Offspring Cohort Study), the presence of an SBI conferred a ≈2-fold increase in incident stroke risk after adjustment for vascular risk factors. These 5 studies had the lowest risk of bias in our assessment and pooled together >9400 subjects totaling ≈78 000 person-years of follow-up, thereby increasing our confidence in the conclusion from this analysis.
Few guidelines exist on how to manage patients with incidentally found SBI. In contrast, professional societies publish detailed guidelines on secondary stroke prevention in patients with clinically overt stroke. 29 Given that the likelihood of a brain lesion presenting clinically depends more on the eloquence of the brain region affected rather than the underlying pathogenesis of the lesion, 30,31 the distinction between silent and overt brain ischemia may need reexamination. In this meta-analysis, we found that SBI confers a similar relative degree of risk of future stroke as a previous history of clinically overt stroke in certain settings. In patients with atrial fibrillation, for example, a previous history of stroke is associated with an HR of 2.3 for recurrent stroke, 32 comparable with the magnitude of risk we determined in our meta-analysis for the first-time symptomatic stroke after SBI. Such considerations raise the question of whether SBI should be considered as a manifestation of cerebrovascular disease that requires intensive evaluation and secondary prevention, as in clinically overt stroke, rather than simply being considered an incidental finding.
Our study has revealed some limitations about the MRI techniques used to detect SBI in the existing body of literature summarizing stroke risk after SBI. First, although there was general agreement on the MRI features of SBI, including size (≥3 mm, T2 hyperintensity distinguishable from leukoaraiosis), we found variability in the methods used to determine the presence of SBI, including MRI magnet field strength (range, 0.2-3.0 T) and specific MRI sequences obtained for evaluation. Most of the included studies (12 of 13) did not perform MRI on higher field strength 3-T magnets, which are becoming increasingly common and are more likely to allow detection of small lesions. The prevalence and predictive value of SBI detected on these higher field MRI magnets require additional study. Furthermore, the methods used to distinguish SBI from perivascular spaces, a potential mimic on imaging studies, were variably reported and raise the possibility that some perivascular spaces were misclassified as SBI. Such misclassification, however, may not significantly affect our study's overall conclusions given recent data suggesting that perivascular spaces are a manifestation of cerebral small vessel disease 33 and that small brain lesions <3 mm that are too small to definitely distinguish from small perivascular spaces are still predictive of incident stroke. 27 Nonetheless, our study suggests that further standardization of SBI definitions would 
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allow for the more widespread use of SBI as an imaging risk biomarker. 6, 34 Several additional limitations of our study are important to consider. First, we performed one of our meta-analyses using a crude RR because the covariate risk factors varied across studies. However, the relatively higher quality studies included in our analysis provided adjusted HRs, and although there were some differences in the specific risk factors for which each study performed statistical correction, it seems unlikely that these relatively minor interstudy differences affected our overall conclusions. Second, given the variability in length of follow-up between studies, the existing data are not amenable to the calculation of absolute stroke rates. Third, there was variable reporting of stroke subtypes (ischemic versus hemorrhagic) in studies. It would seem likely that SBI would more strongly predict ischemic rather than hemorrhage stroke risk, although further work is warranted to investigate this issue. Fourth, it is unclear in a majority of studies, especially the large population-based studies, to what extent imaging confirmation of stroke outcomes occurred. A more standardized definition of stroke outcomes using modern imaging-based criteria would be helpful in future studies of SBI and stroke risk. Fifth, stroke prevention measures have substantially decreased the incidence of stroke 1 since the time many of the cohorts in this study were recruited (some >20 years ago), possibly limiting the validity of using these data to extrapolate stroke risk in present-day populations. Despite this reduction in absolute stroke risk in the general population, we think that the longer term trends in stroke incidence are unlikely to substantially affect our study's main conclusions given that our focus was on RR. Furthermore, to our knowledge, there are no data to suggest that the recent reductions in stroke incidence would be different in patients with or without SBI. Finally, the RR and HR we determined in our meta-analyses are probably most applicable to older adults given that the majority of participants in these studies were middle aged or elderly. Further studies are warranted to assess whether the future stroke risk conferred by SBI in young adults is substantially different compared with relatively older individuals.
In summary, our systematic review and meta-analysis suggests that SBI is significantly associated with an increased risk of symptomatic stroke. Our study specifically suggests that ≈1 in 5 older, stroke-free adults may be harboring an SBI, which may in turn confer more than double the risk of future first-time stroke. These data indicate a need for future studies of in-depth stroke risk evaluations and intensive prevention measures, including lifestyle modification and proven medical therapies for stroke reduction, in patients with these commonly discovered brain lesions. area of abnormal signal intensity in a vascular distribution, at least 3 mm in size with a cerebrospinal fluid density on the subtraction image and, for lesions in the basal ganglia area, distinct separation from the circle of Willis vessels size, location, shape, and tissue contrast to distinguish SBI from dilated perivascular spaces NA 6 Putaala 2011 6 1.0 to 1.5 Tesla not specified not specified ≥ 3 mm focal hyperintensity on T2-weighted images without a corresponding history of neurologic symptoms or signs simultaneous hyperintensity on T2-weighted images and hypointensity on FLAIR images for perivascular spaces as opposed to SBI MRI of the brain studies acquired at the initial presentation for acute ischemic stroke were reinterpreted by study stroke neurologists and a senior neuroradiologist. SBI classification required appropriate imaging criteria as well as no corresponding history of neurologic symptoms or signs. focal hyperintensities on T2-weighted and FLAIR-weighted sequences, 3 mm in diameter, without corresponding neurologic symptoms; leukoaraiosis defined as multifocal or confluent hyperintensities located in periventicular or subcortical regions or in the pontine white matter on T2-weighted or FLAIR sequences. Differentiated from SBIs based on lesion morphology and localization hyperintensity of T2-FLAIR images used to distinguish SBI from dilated perivascular space SBI determined on imaging performed during the patient's initial workup for acute ischemic stroke; consensus of 2 neurologists needed to establish a lesion as an asymptomatic brain infarction using all available clinical data 9 Poels 2012 9 1.5 Tesla 5 or 6 mm 1 or 2 mm at least 3 mm evidence of one or more infarcts on MRI, without a history of (corresponding) stroke or TIA (focal hyperintensities on T2 weighted images); white matter lesions (rather than SBIs) were considered to be present if hyperintensities were visible on proton-density and T2-weighted images, without prominent hypointensities on T1-weighted scans proton density scans were used to distinguish infarcts from dilated perivascular spaces NA 10 Weber 2012 10 Not specified not specified not specified ≥ 3 mm focal hyperintense lesion on T2-weighted images and/or fluid-attenuated inversion recovery with no corresponding symptoms in the clinical history of the patient that could be attributed to the lesion; SBI were distinguished from nonspecific subcortical and periventricular white matter lesions by the presence of a corresponding hypointense lesion on T1-weighted images hyperintensity of T2-FLAIR images used to distinguish SBI from dilated perivascular space
Two study investigators defined SBI on the baseline imaging performed for acute ischemic stroke as chronic lesions with no corresponding symptoms in the clinical history of the patient that could be attributed the presumed SBI; Information about symptoms of the qualifying ischemic stroke was collected using baseline case report forms lesions 3 mm in size and visible on both T1-and proton-density/T2-weighted images were classified as infarcts; an additional analysis was performed on putative vascular lesions <3 mm which were too small to definitely characterize as SBI spin density brigthness used to distinguish SBI from perivascular spaces NA MRI = magnetic resonance imaging; SBI = silent brain infarction; FLAIR = fluid attenuated inversion recovery; NA = not applicable Supplemental an acute disturbance of focal neurological dysfunction with symptoms lasting >24 hours (or resulting in earlier death) and thought to be a result of either cerebral infarction an acute disturbance of focal neurological dysfunction with symptoms lasting >24 hours (or resulting in earlier death) and thought to be a result of either cerebral hemorrhage.
outpatient periodic visits and, in case of missed appointment follow-up, telephone interview; original medical records were also reviewed to determine the occurrence of stroke; all possible events were audited independently by 3 physicians.
Windham 2015 13 evidence of sudden or rapid onset of neurologic symptoms that persisted for more than 24 hours or led to death with no other apparent cause, such as trauma, tumor, infection, or anticoagulation any one of the following criteria: CT or MRI with intraparenchymal hematoma; demonstration at autopsy or surgery; or at least 1 major or 2 minor neurologic deficits, bloody spinal fluid on lumbar puncture, no CT or MRI with or without cerebral angiography demonstrating an avascular mass effect, and no evidence of aneurysm or arteriovenous malformation annual follow-up interviews and community surveillance, including medical record reviews; cases were reviewed separately using a computerized algorithm and a physician reviewer CT = computed tomography; MRI = magnetic resonance imaging Supplemental *data obtained via direct correspondence with study authors MRI = magnetic resonance imaging; SBI = silent brain infarction; CI = confidence interval; HR = hazard ratio; OR = odds ratio; Supplemental *Minimal (+) if studies controlled for 4 of the following 6 potential stroke risk factors which are potential confounders: age, sex, hypertension, diabetes mellitus, coronary artery disease, and smoking history and hyperlipidemia by including these variables in the multivariate model or by ensuring that patients with and without SBI were similar or matched on these variables. Relatively higher risk (-) if studies did not provide adjusted risk metric demonstrating strength of association between SBI and incident stroke.
